These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26446378)
21. Light People: Professor Chennupati Jagadish. Wang H Light Sci Appl; 2021 Jun; 10(1):115. PubMed ID: 34075022 [TBL] [Abstract][Full Text] [Related]
22. A conversation with Paul Greengard. Interview by Eric J Nestler. Greengard P Annu Rev Pharmacol Toxicol; 2013; 53():1-16. PubMed ID: 23294305 [TBL] [Abstract][Full Text] [Related]
23. A profile of Keith AA Fox, cardiologist and researcher. Fox KA; Telfer C Future Cardiol; 2014 Jan; 10(1):27-9. PubMed ID: 24344658 [TBL] [Abstract][Full Text] [Related]
24. Personalized Medicine Across Disciplines and without Borders. Vural Özdemir speaks to Hannah Wilson, Commissioning Editor. Özdemir V Per Med; 2014; 11(7):687-691. PubMed ID: 26120345 [TBL] [Abstract][Full Text] [Related]
25. My thoughts on teaching. Smith BJ J Vet Med Educ; 2009; 36(3):256-9. PubMed ID: 19861711 [TBL] [Abstract][Full Text] [Related]
26. Interview: An architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix. Tomalia DA Nanomedicine (Lond); 2012 Jul; 7(7):953-6. PubMed ID: 22846090 [TBL] [Abstract][Full Text] [Related]
27. Stephen Neidle on cancer therapy and G-quadruplex inhibitors. Interview by Joanna De Souza. Neidle S Drug Discov Today; 2004 Sep; 9(18):778-81. PubMed ID: 15364062 [TBL] [Abstract][Full Text] [Related]
28. The bioprocessing of stem cells: how to reach the clinic. Interviewed by Emily Culme-Seymour. Zandstra P Regen Med; 2013 Jul; 8(4):409-12. PubMed ID: 23826695 [TBL] [Abstract][Full Text] [Related]
29. An interview with Professor Robert J. Lefkowitz, M.D. Interview by Vicki Glaser. Lefkowitz RJ Assay Drug Dev Technol; 2003 Apr; 1(2):233-8. PubMed ID: 15090188 [TBL] [Abstract][Full Text] [Related]
30. Neurovirology: neurotropic viruses and the brain. Interview with Sunit K Singh by Hannah Branch. Singh SK Future Microbiol; 2013 Aug; 8(8):957-9. PubMed ID: 23902142 [TBL] [Abstract][Full Text] [Related]
31. Current targets in irritable bowel syndrome: an interview with Eamonn Quigley. Interview by Emma Quigley. Quigley E Expert Opin Ther Targets; 2006 Jun; 10(3):351-3. PubMed ID: 16706675 [TBL] [Abstract][Full Text] [Related]
32. On the bridge over the translational valley of death: interview with Per I Arvidsson. Arvidsson PI Future Sci OA; 2017 Jun; 3(2):FSO183. PubMed ID: 28670474 [No Abstract] [Full Text] [Related]
35. An interview with Doriano Fabbro, Ph.D., Novartis Biomedical Research Institute. Interviewed by Vicki Glaser. Fabbro D Assay Drug Dev Technol; 2004 Apr; 2(2):109-14. PubMed ID: 15165506 [No Abstract] [Full Text] [Related]
36. An interview with Eric Olson. Eve A Development; 2020 Mar; 147(6):. PubMed ID: 32184270 [TBL] [Abstract][Full Text] [Related]
37. Investigator profile. An interview with Zuoyan Zhu, Ph.D., Professor, Institute of Hydrobiology, Chinese Academy of Sciences, Beijing, China. Interview by Vicki Glaser. Zhu Z Zebrafish; 2005; 2(1):1-5. PubMed ID: 18248174 [TBL] [Abstract][Full Text] [Related]
38. Interview: partnering with the industry: the Olympic laboratory model. Cowan DA; Barker CP Bioanalysis; 2012 Jul; 4(13):1545-8. PubMed ID: 22831471 [TBL] [Abstract][Full Text] [Related]
39. Synergy between medicinal chemistry and biological research. Moncada S; Coaker H Future Med Chem; 2014 Sep; 6(13):1481-3. PubMed ID: 25365232 [TBL] [Abstract][Full Text] [Related]